Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Patient Satisfaction 2Urologic Neoplasms 1Thyroid Cancer, Papillary 1Sarcoma, Ewing 1Sarcoma 1Radiation Injuries 1Patient Preference 1Patient Acceptance of Health Care 1Osteosarcoma 1Osteitis Deformans 1Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Surveys and Questionnaires 3delta 24-sterol reductase 2Urinary Diversion 2Surgical Procedures, Operative 2Propofol 2daratumumab 1Vascular Access Devices 1Uterine Artery Embolization 1Tranexamic Acid 1Telemedicine 1Pilot Projects 1Patient Transfer 1Parapsychology 1Music Therapy 1Midazolam 1Mastectomy, Segmental 1Lidocaine 1Lead 1Imiquimod 1Ibuprofen 1Fentanyl 1Exercise 1Drainage 1Cystectomy 1Control Groups 1Colonoscopy 1Bandages, Hydrocolloid 1Anesthesia, Local 1Ambulatory Care 1Alfentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Patient Satisfaction × delta 24-sterol reductase × Clear all
NCT05236218 2023-03-08

To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).

King's College London

Unknown
60 enrolled

Patient Satisfaction, Patient Preference

NCT04590976 2023-02-08

IP5-MATTER

Imperial College London

Completed
320 enrolled
Genitourinary

Patient Acceptance of Health Care, Radiation Injuries, Urologic Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡